by Fou | 2022-01-27 | Publikationer
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion. van Vollenhoven RF, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Sasso EH, Hwang...
by Fou | 2022-01-27 | Publikationer
Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study. de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes...
by Fou | 2022-01-27 | Publikationer
Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study. Andersson ML, Forslind K, Hafström I. Open Rheumatol J. 2015 Feb 3;9:8-15.
by Fou | 2022-01-25 | Publikationer
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van...
by Fou | 2022-01-25 | Publikationer
The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis. van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AH. Ann Rheum Dis. 2015 Jan;74(1):e3.
